Clinical trial

Vitamin D, K2 Plus Empagliflozin Combination in Type Two Diabetes Mellitus

NCT05417880

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2022-08-01

PhasePHASE3

Study timeline

Study start (estimated)2022-08-01Date precision: month

Registry last updated2022-06-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitusunresolved

Interventions

Oral Hypoglycemic Agents,OralDRUG

VoretaDRUG

Voreta plus SunnyD PRODRUG

Sponsors & collaborators

Scotmann Pharmaceuticalslead sponsor

University of Health Sciences Lahorecollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05417880 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.